According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period.
The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Quetiapine Fumarate. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Quetiapine Fumarate market.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Key Features:
The report on Quetiapine Fumarate market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Quetiapine Fumarate market. It may include historical data, market segmentation by Type (e.g., Immediate Release Tablets, Extended Release Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Quetiapine Fumarate market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Quetiapine Fumarate market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Quetiapine Fumarate industry. This include advancements in Quetiapine Fumarate technology, Quetiapine Fumarate new entrants, Quetiapine Fumarate new investment, and other innovations that are shaping the future of Quetiapine Fumarate.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Quetiapine Fumarate market. It includes factors influencing customer ' purchasing decisions, preferences for Quetiapine Fumarate product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Quetiapine Fumarate market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Quetiapine Fumarate market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Quetiapine Fumarate market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Quetiapine Fumarate industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Quetiapine Fumarate market.
Market Segmentation:
Quetiapine Fumarate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Immediate Release Tablets
Extended Release Tablets
Segmentation by application
Adult
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Quetiapine Fumarate market?
What factors are driving Quetiapine Fumarate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Quetiapine Fumarate market opportunities vary by end market size?
How does Quetiapine Fumarate break out type, application?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Quetiapine Fumarate Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Quetiapine Fumarate by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Quetiapine Fumarate by Country/Region, 2019, 2023 & 2030 2.2 Quetiapine Fumarate Segment by Type 2.2.1 Immediate Release Tablets 2.2.2 Extended Release Tablets 2.3 Quetiapine Fumarate Sales by Type 2.3.1 Global Quetiapine Fumarate Sales Market Share by Type (2019-2024) 2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2019-2024) 2.3.3 Global Quetiapine Fumarate Sale Price by Type (2019-2024) 2.4 Quetiapine Fumarate Segment by Application 2.4.1 Adult 2.4.2 Others 2.5 Quetiapine Fumarate Sales by Application 2.5.1 Global Quetiapine Fumarate Sale Market Share by Application (2019-2024) 2.5.2 Global Quetiapine Fumarate Revenue and Market Share by Application (2019-2024) 2.5.3 Global Quetiapine Fumarate Sale Price by Application (2019-2024) 3 Global Quetiapine Fumarate by Company 3.1 Global Quetiapine Fumarate Breakdown Data by Company 3.1.1 Global Quetiapine Fumarate Annual Sales by Company (2019-2024) 3.1.2 Global Quetiapine Fumarate Sales Market Share by Company (2019-2024) 3.2 Global Quetiapine Fumarate Annual Revenue by Company (2019-2024) 3.2.1 Global Quetiapine Fumarate Revenue by Company (2019-2024) 3.2.2 Global Quetiapine Fumarate Revenue Market Share by Company (2019-2024) 3.3 Global Quetiapine Fumarate Sale Price by Company 3.4 Key Manufacturers Quetiapine Fumarate Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Quetiapine Fumarate Product Location Distribution 3.4.2 Players Quetiapine Fumarate Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Quetiapine Fumarate by Geographic Region 4.1 World Historic Quetiapine Fumarate Market Size by Geographic Region (2019-2024) 4.1.1 Global Quetiapine Fumarate Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Quetiapine Fumarate Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Quetiapine Fumarate Market Size by Country/Region (2019-2024) 4.2.1 Global Quetiapine Fumarate Annual Sales by Country/Region (2019-2024) 4.2.2 Global Quetiapine Fumarate Annual Revenue by Country/Region (2019-2024) 4.3 Americas Quetiapine Fumarate Sales Growth 4.4 APAC Quetiapine Fumarate Sales Growth 4.5 Europe Quetiapine Fumarate Sales Growth 4.6 Middle East & Africa Quetiapine Fumarate Sales Growth 5 Americas 5.1 Americas Quetiapine Fumarate Sales by Country 5.1.1 Americas Quetiapine Fumarate Sales by Country (2019-2024) 5.1.2 Americas Quetiapine Fumarate Revenue by Country (2019-2024) 5.2 Americas Quetiapine Fumarate Sales by Type 5.3 Americas Quetiapine Fumarate Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Quetiapine Fumarate Sales by Region 6.1.1 APAC Quetiapine Fumarate Sales by Region (2019-2024) 6.1.2 APAC Quetiapine Fumarate Revenue by Region (2019-2024) 6.2 APAC Quetiapine Fumarate Sales by Type 6.3 APAC Quetiapine Fumarate Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Quetiapine Fumarate by Country 7.1.1 Europe Quetiapine Fumarate Sales by Country (2019-2024) 7.1.2 Europe Quetiapine Fumarate Revenue by Country (2019-2024) 7.2 Europe Quetiapine Fumarate Sales by Type 7.3 Europe Quetiapine Fumarate Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Quetiapine Fumarate by Country 8.1.1 Middle East & Africa Quetiapine Fumarate Sales by Country (2019-2024) 8.1.2 Middle East & Africa Quetiapine Fumarate Revenue by Country (2019-2024) 8.2 Middle East & Africa Quetiapine Fumarate Sales by Type 8.3 Middle East & Africa Quetiapine Fumarate Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Quetiapine Fumarate 10.3 Manufacturing Process Analysis of Quetiapine Fumarate 10.4 Industry Chain Structure of Quetiapine Fumarate 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Quetiapine Fumarate Distributors 11.3 Quetiapine Fumarate Customer 12 World Forecast Review for Quetiapine Fumarate by Geographic Region 12.1 Global Quetiapine Fumarate Market Size Forecast by Region 12.1.1 Global Quetiapine Fumarate Forecast by Region (2025-2030) 12.1.2 Global Quetiapine Fumarate Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Quetiapine Fumarate Forecast by Type 12.7 Global Quetiapine Fumarate Forecast by Application 13 Key Players Analysis 13.1 AstraZeneca 13.1.1 AstraZeneca Company Information 13.1.2 AstraZeneca Quetiapine Fumarate Product Portfolios and Specifications 13.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 AstraZeneca Main Business Overview 13.1.5 AstraZeneca Latest Developments 13.2 Intas 13.2.1 Intas Company Information 13.2.2 Intas Quetiapine Fumarate Product Portfolios and Specifications 13.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Intas Main Business Overview 13.2.5 Intas Latest Developments 13.3 TAPI 13.3.1 TAPI Company Information 13.3.2 TAPI Quetiapine Fumarate Product Portfolios and Specifications 13.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 TAPI Main Business Overview 13.3.5 TAPI Latest Developments 13.4 Accord 13.4.1 Accord Company Information 13.4.2 Accord Quetiapine Fumarate Product Portfolios and Specifications 13.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Accord Main Business Overview 13.4.5 Accord Latest Developments 13.5 Hexal 13.5.1 Hexal Company Information 13.5.2 Hexal Quetiapine Fumarate Product Portfolios and Specifications 13.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Hexal Main Business Overview 13.5.5 Hexal Latest Developments 13.6 Dr.Reddy's 13.6.1 Dr.Reddy's Company Information 13.6.2 Dr.Reddy's Quetiapine Fumarate Product Portfolios and Specifications 13.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Dr.Reddy's Main Business Overview 13.6.5 Dr.Reddy's Latest Developments 13.7 Lupin 13.7.1 Lupin Company Information 13.7.2 Lupin Quetiapine Fumarate Product Portfolios and Specifications 13.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Lupin Main Business Overview 13.7.5 Lupin Latest Developments 13.8 Sun Pharmaceutical 13.8.1 Sun Pharmaceutical Company Information 13.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications 13.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Sun Pharmaceutical Main Business Overview 13.8.5 Sun Pharmaceutical Latest Developments 13.9 Hunan Dongting Pharm 13.9.1 Hunan Dongting Pharm Company Information 13.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolios and Specifications 13.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Hunan Dongting Pharm Main Business Overview 13.9.5 Hunan Dongting Pharm Latest Developments 13.10 SuZhou NO.4 Phamaceutical Factory 13.10.1 SuZhou NO.4 Phamaceutical Factory Company Information 13.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolios and Specifications 13.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 SuZhou NO.4 Phamaceutical Factory Main Business Overview 13.10.5 SuZhou NO.4 Phamaceutical Factory Latest Developments 13.11 Fuan Pharmaceutical 13.11.1 Fuan Pharmaceutical Company Information 13.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications 13.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fuan Pharmaceutical Main Business Overview 13.11.5 Fuan Pharmaceutical Latest Developments 13.12 Zhejiang Supor Pharmaceuticals 13.12.1 Zhejiang Supor Pharmaceuticals Company Information 13.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolios and Specifications 13.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Zhejiang Supor Pharmaceuticals Main Business Overview 13.12.5 Zhejiang Supor Pharmaceuticals Latest Developments 13.13 Zhejiang Huahai Pharmaceutical 13.13.1 Zhejiang Huahai Pharmaceutical Company Information 13.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications 13.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Zhejiang Huahai Pharmaceutical Main Business Overview 13.13.5 Zhejiang Huahai Pharmaceutical Latest Developments 14 Research Findings and Conclusion